| Date Filed | Type | Description |
| 10/05/2023 |
4
| Luthringer Remy (CEO) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Granted 100,450 options to buy
@ $6.41, valued at
$643.9k
|
|
| 10/05/2023 |
4
| Race Geoff (President) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Granted 87,050 options to buy
@ $6.41, valued at
$558k
|
|
| 10/05/2023 |
4
| Ahlholm Frederick W (SVP, CFO and Secretary) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Granted 42,850 options to buy
@ $6.41, valued at
$274.7k
|
|
| 09/29/2023 |
4
| HASLER HANS PETER (Director) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Granted 12,500 options to buy
@ $7.3, valued at
$91.3k
|
|
| 09/29/2023 |
4
| VAN HEEK G JAN (Director) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Granted 12,500 options to buy
@ $7.3, valued at
$91.3k
|
|
| 09/29/2023 |
4
| HILLEMAN JERYL L (Director) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Granted 12,500 options to buy
@ $7.3, valued at
$91.3k
|
|
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2023 |
8-K
| Quarterly results |
| 08/15/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 08/15/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 08/15/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 08/10/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/09/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 08/04/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 08/01/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/07/2023 |
3
| BOEHRINGER INGELHEIM INTERNATIONAL GMBH (10% Owner) has filed a Form 3 on Minerva Neurosciences, Inc. |
| 07/03/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/05/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/02/2023 |
4
| Luthringer Remy (CEO) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Granted 88,077 shares
@ $0
Sold 23,753 shares
@ $3.85, valued at
$91.4k
Sold 3,641 shares
@ $3.76, valued at
$13.7k
|
|
| 05/02/2023 |
4
| Race Geoff (President) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Granted 46,987 shares
@ $0
Sold 22,082 shares
@ $3.85, valued at
$85k
|
|
| 05/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/01/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 04/20/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
| 03/08/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0% stake in Minerva Neurosciences, Inc. |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 3.6% stake in Minerva Neurosciences Inc. |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 22.5% stake in MINERVA NEUROSCIENCES, INC. |
| 12/28/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 12/16/2022 |
8-K
| Quarterly results |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|